Jason Butler

Stock Analyst at Citizens Capital Markets

(0.27)
# 1870
Out of 5,291 analysts
185
Total ratings
35.34%
Success rate
6.12%
Average return
42 Stocks
Name Action Price Target Current % Upside Ratings Updated
Precigen
Reiterates: Market Outperform
6 6
1.58 279.75% 9 Mar 20, 2025
Abivax
Reiterates: Market Outperform
33 33
6.48 409.26% 2 Mar 18, 2025
Zevra Therapeutics
Maintains: Market Outperform
17 18
7.83 129.89% 2 Mar 12, 2025
Esperion Therapeutic...
Reiterates: Market Outperform
4 4
1.5 166.67% 6 Mar 5, 2025
argenx
Maintains: Outperform
696 701
588.92 19.03% 8 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
80 80
13.15 508.37% 8 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
29 33
13.66 141.58% 1 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
8 9
2.92 208.22% 8 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
78 78
43.2 80.56% 14 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
22
1.91 1051.83% 4 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
72 73
63.76 14.49% 13 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
9 9
3.01 199% 7 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
39 39
11.04 253.26% 4 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 7 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
50 23
1.19 1832.77% 3 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
19
6.74 181.9% 6 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
44 39
17.06 128.6% 12 Mar 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 11 Jan 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 7 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
17
n/a n/a 3 Nov 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
42 38
14.47 162.61% 7 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Outperform
22
1.42 1449.3% 1 Sep 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
50
1.2 4066.67% 2 May 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 3 Dec 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Aug 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jan 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Outperform
1200
0.24 499900% 1 Dec 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
111 116
5.71 1931.52% 4 Nov 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
7 9
3.5 157.14% 1 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 3 Oct 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Dec 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 3 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Sep 5, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
24 21
131.81 -84.07% 4 Aug 8, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
42 43
n/a n/a 2 Oct 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
4 2
n/a n/a 3 Aug 9, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Outperform
56
n/a n/a 1 Nov 27, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Apr 3, 2017